Presentation : preoperative HIV testing : is it less expensive than universal precautions ?
Universal precautions are officially recommended to prevent HIV transmission in health care settings but for elective surgery some advocate routine preoperative HIV testing.
These strategies have not been tested in clinical trials but universal precautions are very expensive and not cost-effective.
Thus, for elective surgery, routine testing might save resources by permitting selective use of additional barrier precautions.
We performed an economic evaluation to compare both strategies, using a simple approach to determine if routine testing (RT) is less expensive than universal precautions (UP).
Conservatively assuming equal effectiveness in preventing HIV transmission, we compared a minimized estimate for the average cost of RT with a maximized estimate for the average cost of UP per elective operation.
Mots-clés Pascal : Dépistage, Virus immunodéficience humaine, Préopératoire, SIDA, Analyse avantage coût, Economie santé, Prévention, Milieu hospitalier, Homme, Exposition professionnelle, Personnel sanitaire, Etats Unis, Méthodologie, Lentivirinae, Retroviridae, Virus, Virose, Infection, Amérique du Nord, Amérique, Immunopathologie, Hémopathie
Mots-clés Pascal anglais : Medical screening, Human immunodeficiency virus, Preoperative, AIDS, Cost benefit analysis, Health economy, Prevention, Hospital environment, Human, Occupational exposure, Health staff, United States, Methodology, Lentivirinae, Retroviridae, Virus, Viral disease, Infection, North America, America, Immunopathology, Hemopathy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0048474
Code Inist : 002B30A03C. Création : 199406.